Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
This product is available as 5mg and 10mg of lyophilised research material
Symptoms are often most noticeable with the first dose and may improve over time
[7] PharmaCotherapia d.o.o., Phase I, Pilot Study in Healthy Volunteers, to Assess the Safety and Pharmacokinetics of PCO-02, Which Active Ingredient is BPC-157, a Penta-deca-peptide From Gastric Source., clinicaltrials.gov, Clinical trial registration NCT02637284, Dec
This study enrolled adults aged 18 years or older who were diagnosed with obesity, defined either through diagnostic codes E66.0 and E66.9 or a Body Mass Index (BMI) of 30 or above, and who had 2 medical encounters related to this diagnosis in the database
2022 Oct 25;10(11):2696
US$ 21.90
US$ 24.97
US$ 21.72
